The challenge moving forward is to elucidate the complex mechanism of TGF-β signaling with relation to the other various signaling pathways and to find effective therapeutic agents targeting TGF-β signaling in the regulation of intestinal fibrosis in IBD. Here, TGFB1 is linked to inflammatory bowel disease.